South Asia Journal Watch
South Asia Journal Watch: 22 November 2026
Microbiology, infectious disease, AMR and infection-control papers from India and South Asia added to PubMed on 20 to 22 November 2026 and not covered in earlier issues.
Lead articles
Lymphatic filariasis · Retrospective cohort · iScience
Determinants of progression of filarial lymphedema in a clinic-based cohort: Implications for global elimination
iScience · doi:10.1016/j.isci.2026.118171 · PubMed 43061521
- What
- A study of the long-term clinical course of filarial lower-limb lymphoedema and the factors associated with change in limb volume.
- Design
- Retrospective cohort of 110 adult patients with filarial lower-limb lymphoedema in Puducherry, India, followed for a median of nine years (ICMR National Institute for Vector Control Research, Puducherry). Limb volume change was objectively quantified, and determinants of progression were assessed by multivariable regression.
- Key findings
- Nearly half of the cohort (46.4%) showed no volumetric progression over follow-up. Recurrent adenolymphangitis episodes and baseline hypertension correlated with the severity of progression. In multivariable regression, strict adherence to home-based morbidity management and disability prevention (MMDP) self-care practices was the primary independent predictor of halted or reduced limb volume change. The authors concluded that sustained adherence to simple self-care interventions can mitigate chronic lymphoedema.
- Limitations
- Retrospective, single clinic-based cohort; the abstract does not report effect sizes for the predictors or describe how self-care adherence was measured, and the findings may not apply to patients outside clinic follow-up.
- Relevance to South Asia
- Lymphatic filariasis remains endemic in parts of India, where MMDP is a core component of the elimination programme; this cohort provides long-term outcome data from an Indian clinical setting.
Vaccines · Systematic review and meta-analysis · Human Vaccines & Immunotherapeutics
Cross-protective immune responses to pneumococcal serotype 6A following vaccination with 6B-containing pneumococcal conjugate vaccines: A systematic review and meta-analysis
Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2762621 · PubMed 43059099
- What
- A systematic review and meta-analysis of serotype 6A-specific immune responses after vaccination with pneumococcal conjugate vaccines (PCVs) containing serotype 6B, which may give cross-protection against 6A.
- Design
- Databases were searched for studies reporting IgG geometric mean concentrations (GMCs), proportions achieving IgG ≥ 0.35 µg/mL, and opsonophagocytic activity (OPA) titres. Forty-three studies met the inclusion criteria and eight contributed quantitative data (PROSPERO CRD420251134118). The authors are based in Mumbai and Delhi.
- Key findings
- Overall, 6B-containing vaccines elicited measurable cross-reactive IgG and functional responses against serotype 6A. Booster-containing 3 + 1 schedules showed numerically higher responses than 3 + 0 schedules, with pooled IgG GMCs of 1.63 vs. 0.59 µg/mL, proportions achieving IgG ≥ 0.35 µg/mL of 92.78% vs. 65.38%, and OPA GMTs of 984.6 vs. 169.2, respectively.
- Limitations
- Only eight of the 43 included studies contributed quantitative data; outcomes are immunogenicity measures rather than clinical protection, and the abstract does not report heterogeneity or a formal statistical comparison between schedules.
- Relevance to South Asia
- The authors note that India bears a pneumococcal disease burden, with serogroup 6 contributing to invasive pneumococcal disease, acute otitis media and nasopharyngeal carriage.
More from the journals
Antimicrobial resistance and novel agents
- A neutral-pH buffered plasma-activated water formulation killed ESKAPE pathogens through reactive nitrogen species, particularly peroxynitrite; it reduced bacterial burden on metal surfaces and in infected wounds in vivo, with greater in vitro killing than high concentrations of ceftazidime, ciprofloxacin and meropenem (Indian Institute of Science, Bangalore)iScience · PubMed 43061271
Parasitic, vector-borne and zoonotic infections
- Protocol for a type 1 hybrid effectiveness-implementation study of a digital adherence system to improve completion of rabies post-exposure prophylaxis in peri-urban Odisha (ICMR-National Institute of Health Research, Bhubaneswar)BMJ Open · PubMed 43064372
- The 2026 Cyclospora outbreak in the United States as a prompt for foodborne disease surveillance in India (GMCH Chandigarh and AIIMS Bilaspur; letter)Tropical Doctor · PubMed 43061895
Mycology
- A marine bacterial chitinase (BtChi) showed activity against Candida species, with MICs of 7.8 to 250 µg/mL; C. auris had MIC50 and MIC90 values of 3.9 µg/mL and 7.8 µg/mL, but reductions of only 0.4 log10 CFU/mL in time-kill assays (Manipal Institute of Technology)Applied Microbiology and Biotechnology · PubMed 43062486
Other: environmental microbiology
- Shotgun metagenomics of the Shitalakshya River, Bangladesh, in early (December 2024) and peak (February 2025) dry season: ammonia nearly doubled (5 → 9.87 mg L⁻¹) and more VFDB-annotated virulence-associated genes were detected in February (378 vs. 294), with biofilm determinants newly detected (University of Dhaka)PLOS ONE · PubMed 43063148
Items are summaries of published abstracts and are not clinical advice. Readers should consult the original article. Figures are quoted as reported in each abstract.